Ending the epidemic

ENDING THE HIV EPIDEMIC

WE WON’T STOP UNTIL WE END HIV.

At ViiV healthcare, our goal is ambitious, yet clear: we want to end the HIV epidemic. We believe we have the tools to achieve this goal through continuous innovation, talented people and global partnerships that help us reach the communities that are disproportionately impacted by HIV. We must keep investing in the global HIV response.

Explore this section as we spotlight the collective efforts of our people, community, innovation and our overall commitment with only one goal in mind: to end HIV. 

We can end the HIV epidemic. Full stop.

OUR FOCUS AREAS

Click on each article to find out more about our key focus areas

Our people are central to our mission. We unite our talent to drive innovation and positive change for people living with HIV around the world. Learn more about our people.

What makes us unique is our partnerships with the HIV community. Learn more about how we’re working directly alongside the HIV community to make meaningful change on the ground.

Why are we leaders in innovation? Because we listen. We embed patient insights into our pipeline strategy to develop treatment and prevention options that suit the evolving needs of people living with HIV

Our commitment to ending the HIV epidemic is grounded in everything we do. We are working hard to combat HIV related stigma, amplify the voices of underrepresented communities and challenging global health systems

WHAT WILL IT TAKE TO END HIV? IT TAKES A VILLAGE

Read more stories from ViiV here

In this article by Professor José Gatell, he shares his insights on what multidrug-resistance HIV is and his insights on how to manage such a complex condition.

In this article, Mercy Shibemba shares her hopes and aspirations for the future. She reflects on how living with HIV shaped her childhood and how her concept of healthy living may shift as she gets older.

To lift the substantial burdens of daily treatment and social stigma associated with HIV. A cure is essential towards accomplishing our goal of ending the HIV epidemic. With this goal in mind, we are in pursuit of a cure for HIV.

NP-GBL-HVX-COCO-240022 July 2024

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.